We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal grand jury in Virginia has indicted drugmaker Indivior for allegedly running a nationwide scheme to increase subscriptions of its Suboxone film (buprenorphine and naloxone) opioid dependence treatment. Read More
Those who defend the current drug rebate system are defending higher list prices and costs for customers, HHS Secretary Alex Azar said on Wednesday in a speech to independent pharmacists. Read More
Congress should eliminate copays for insulin rather than focus on the life-saving biologics’ list price, an executive with one of the nation’s largest drugmakers said Wednesday. Read More
House representatives on both sides of the aisle expressed support for a new drug pricing bill during a Ways and Means Committee markup on Tuesday, calling it a good first step. Read More
Pharmacy benefit managers took their turn on the drug pricing hot seat Tuesday as Senators grilled five executives about their role in a system that both parties agree is out of control. Read More